Electric field therapy for breast cancer that has spread
Part of Cancer, Skin clinical trials.
This trial tests a new way to treat breast cancer that has spread to the skin or just under the skin. It uses short electric pulses to target tumors without cutting. The goal is to see if this approach can safely destroy cancer cells in those spots.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have breast cancer that has spread to other parts of the body (metastatic).
- You have at least one tumor under the skin that is between 1 and 5 centimeters (about half an inch to 2 inches).
- You are able to pause your regular cancer treatment for 1 week before and 2 weeks after the procedure.
- You are 18 years or older.
- You are not taking blood thinners, or can safely stop them for the procedure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a device that uses radiofrequency energy to help remove breast cancer during surgery. It may be an option for women over 50 with a specific type of early-stage breast cancer.
This study tests if a new treatment called IRE (irreversible electroporation) can safely treat small, early-stage breast cancers. It's for people with a single, small tumor that has not been treated yet.
This Phase 2 study tests whether treating a small number of metastatic spots with a local approach (like targeted radiation, surgery, or ablation) can help people with ER/PR-positive breast cancer. It aims to help when the cancer has spread only to a few areas and has not significantly worsened after initial whole-body treatment.
This study tests a new device that uses brief electrical pulses (pulsed electric field or PEF) to treat lung tumors before they are surgically removed. The goal is to see if this approach can be safely added to standard lung cancer surgery.
This trial tests a new treatment that uses short electric pulses (pulsed electric field) to target and damage cancer cells in the esophagus. It is for people with advanced esophageal cancer that cannot be removed by surgery, and it aims to be safe and potentially shrink or slow the tumor.
This trial tests a new treatment that uses short electrical pulses (pulsed electric field ablation) to destroy small lung tumors. It may be an option for people with limited, early-stage non-small cell lung cancer who can tolerate a minimally invasive procedure.
Hear when a new Metastatic Breast Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.